Artificial heart maker Carmat to launch capital increase soon

Adds annual revenue, outlook, manufacturing capacity from paragraph 2

PARIS, Jan 15 (Reuters) - French artificial heart maker Carmat ALCAR.PA said on Monday that it would soon launch a capital increase, estimated to raise at least 50 million euros ($54.8 million), to ensure it had enough financing for the next 12 months.

Carmat, which survived a cash crunch in mid-October, said it had generated annual revenue of 2.8 million euros.

This corresponds to the sale of 17 of its Aeson prostheses, including 11 in the last quarter of 2023, confirming it accelerated the pace of implants.

It also said it sees sales between 14 million and 20 million euros in 2024.

The company confirmed its previously announced target to increase its manufacturing capacity to 500 hearts per year from early 2024, with the opening of a second production facility in Bois-d'Arcy.

($1 = 0.9123 euros)

(Reporting by Sudip Kar-Gupta in Paris, Michal Aleksandrowicz in Gdansk; Editing by Edmund Klamann)


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.